Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:II-361-II-364

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canty, T. G.
Right arrow Articles by Pohlman, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canty, T. G., Jr
Right arrow Articles by Pohlman, T. H.
Related Collections
Right arrow Gene expression
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 1999;100:II-361.)
© 1999 American Heart Association, Inc.


Myocardial Protection and Vascular Biology

Oxidative Stress Induces NF-{kappa}B Nuclear Translocation Without Degradation of I{kappa}B{alpha}

Timothy G. Canty, Jr, MD; Edward M. Boyle, Jr, MD; Angie Farr, BS; Elizabeth N. Morgan, MD; Edward D. Verrier, MD; Timothy H. Pohlman, MD

From the Department of Surgery, University of Washington, Seattle.

Correspondence to Timothy H. Pohlman, Department of Surgery, University of Washington, Harborview Medical Center, Box 359796, Seattle, WA 98104-2924. E-mail tpohlman{at}u.washington.edu

Background—Rel/NF-{kappa}B, an oxidative stress–responsive transcription factor, participates transiently in the control of gene expression. The cellular mechanisms that mediate NF-{kappa}B activation during ischemia (and during reperfusion in the course of treating ischemia) are not known.

Methods and Results—To investigate the NF-{kappa}B activation induced during oxidative stress, we examined human cardiac tissue obtained during surgical procedures requiring cardiopulmonary bypass. In vitro, we examined human umbilical vein endothelial cells (HUVECs) exposed to hypoxia, reoxygenation after hypoxia, or a reactive oxygen intermediate (H2O2). Electrophoretic mobility shift assays performed on right atrial tissue revealed prominent NF-{kappa}B activation after hearts had been exposed to ischemia and reperfusion. The assays also showed that NF-{kappa}B activation was observed in hypoxic HUVECs after reoxygenation and in cultures treated with H2O2 (500 µmol/L). Pervanadate (200 µmol/L) also induced marked NF-{kappa}B activation in HUVECs, indicating that H2O2-induced NF-{kappa}B activation is potentiated by the inhibition of tyrosine phosphatases. Western blotting of cytoplasmic I{kappa}B{alpha} demonstrated that NF-{kappa}B activation induced by oxidative stress was not associated with I{kappa}B{alpha} degradation. In contrast, tumor necrosis factor-{alpha}–induced NF-{kappa}B activation occurred in concert with degradation of I{kappa}B{alpha}. Inhibition of I{kappa}B{alpha} degradation with a proteasome inhibitor, MG-115, blocked NF-{kappa}B activation induced by tumor necrosis factor-{alpha}; however, MG-115 had no effect on NF-{kappa}B activation during oxidative stress.

Conclusions—This study demonstrated a stimulus-specific mechanism of NF-{kappa}B activation in endothelial cells that acts independently of I{kappa}B{alpha} degradation and may require tyrosine phosphorylation.


Key Words: cardiopulmonary bypass • ischemia • reperfusion • endothelium